Search Results - "Current opinion in pharmacology"

Refine Results
  1. 1

    The role of gut microbiota in obesity, diabetes mellitus, and effect of metformin: new insights into old diseases by Pascale, Alessia, Marchesi, Nicoletta, Govoni, Stefano, Coppola, Adriana, Gazzaruso, Carmine

    Published in Current opinion in pharmacology (01-12-2019)
    “…There is a recent growing evidence that abnormalities in the microbiota composition can have a major role in the development of obesity and diabetes and that…”
    Get full text
    Journal Article
  2. 2

    Flavonoids in hypertension: a brief review of the underlying mechanisms by Maaliki, Dina, Shaito, Abdullah A, Pintus, Gianfranco, El-Yazbi, Ahmed, Eid, Ali H

    Published in Current opinion in pharmacology (01-04-2019)
    “…Different pathways implicated in the effects of flavonoids on blood pressure regulation. [Display omitted] •Increased flavonoid consumption imparts…”
    Get full text
    Journal Article
  3. 3

    PD-1/PD-L1 inhibitors by Sunshine, Joel, Taube, Janis M

    Published in Current opinion in pharmacology (01-08-2015)
    “…Highlights • Remarkable and durable anti-tumor activity with several anti-PD-1/PD-L1 antibodies. • FDA approval for anti-PD-1 antibodies for advanced melanoma…”
    Get full text
    Journal Article
  4. 4

    Update on the antibiotic resistance crisis by Rossolini, Gian Maria, Arena, Fabio, Pecile, Patrizia, Pollini, Simona

    Published in Current opinion in pharmacology (01-10-2014)
    “…Highlights • The antibiotic resistance crisis is jeopardizing feasibility of medical practices. • The antibiotic resistance crisis is more serious with…”
    Get full text
    Journal Article
  5. 5

    Focus on the essentials: tryptophan metabolism and the microbiome-gut-brain axis by Gheorghe, Cassandra Elise, Martin, Jason A, Manriquez, Francisca Villalobos, Dinan, Timothy G, Cryan, John F, Clarke, Gerard

    Published in Current opinion in pharmacology (01-10-2019)
    “…[Display omitted] The gut-brain axis is a bidirectional communication system between the central nervous system and the gastrointestinal tract, in which…”
    Get full text
    Journal Article
  6. 6

    Cancer cell and macrophage cross-talk in the tumor microenvironment by Dehne, Nathalie, Mora, Javier, Namgaladze, Dmitry, Weigert, Andreas, Brüne, Bernhard

    Published in Current opinion in pharmacology (01-08-2017)
    “…•The tumor microenvironment contains innate immune cells, for example, macrophages.•Hypoxia imposes stress to tumor cells and their environment.•Tumor cell…”
    Get full text
    Journal Article
  7. 7

    Parathyroid hormone: anabolic and catabolic actions on the skeleton by Silva, Barbara C, Bilezikian, John P

    Published in Current opinion in pharmacology (01-06-2015)
    “…Highlights • Parathyroid hormone has dual anabolic and catabolic actions on the skeleton. • The OPG–RANKL–RANK pathway is the main mediator of the catabolic…”
    Get full text
    Journal Article
  8. 8

    Muscle as a paracrine and endocrine organ by Giudice, Jimena, Taylor, Joan M

    Published in Current opinion in pharmacology (01-06-2017)
    “…Highlights • Skeletal muscle secretes myokines that exert autocrine paracrine and endocrine effects. • Paracrine factors modulate muscle angiogenesis,…”
    Get full text
    Journal Article
  9. 9

    Obesity and cancer: inflammation bridges the two by Kolb, Ryan, Sutterwala, Fayyaz S, Zhang, Weizhou

    Published in Current opinion in pharmacology (01-08-2016)
    “…Highlights • Obesity is associated with chronic inflammation and chronic diseases. • Obesity is associated with increased risk and progression of several…”
    Get full text
    Journal Article
  10. 10

    Adipose tissue inflammation in obesity: a metabolic or immune response? by Stolarczyk, Emilie

    Published in Current opinion in pharmacology (01-12-2017)
    “…•Immunometabolism of the adipose tissue affects insulin resistance and obesity.•Type 2 immune response protects against diet-induced obesity.•Cytokines…”
    Get full text
    Journal Article
  11. 11

    Targeting CD73 to augment cancer immunotherapy by Roh, Meejeon, Wainwright, Derek A, Wu, Jennifer D, Wan, Yong, Zhang, Bin

    Published in Current opinion in pharmacology (01-08-2020)
    “…•CD73 is a multifunctional ectoenzyme affecting both tumor cells and immune cells.•CD73 has been hijacked by TME to promote tumor growth and…”
    Get full text
    Journal Article
  12. 12

    Immunosuppressive activities of adenosine in cancer by Allard, Bertrand, Beavis, Paul A, Darcy, Phillip K, Stagg, John

    Published in Current opinion in pharmacology (01-08-2016)
    “…Highlights • Adenosine protects tissues against excessive inflammation and promotes tissue repair. • The adenosine pathway is hijacked to dampen anti-tumor…”
    Get full text
    Journal Article
  13. 13

    The molecular link between oxidative stress, insulin resistance, and type 2 diabetes: A target for new therapies against cardiovascular diseases by Andreadi, Aikaterini, Bellia, Alfonso, Di Daniele, Nicola, Meloni, Marco, Lauro, Renato, Della-Morte, David, Lauro, Davide

    Published in Current opinion in pharmacology (01-02-2022)
    “…Type 2 Diabetes Mellitus (T2D) is a chronic disease with a pandemic incidence whose pathogenesis has not yet been clarified. Raising evidence highlighted the…”
    Get full text
    Journal Article
  14. 14

    Targeting the renin–angiotensin system as novel therapeutic strategy for pulmonary diseases by Tan, Wan Shun Daniel, Liao, Wupeng, Zhou, Shuo, Mei, Dan, Wong, Wai-Shiu Fred

    Published in Current opinion in pharmacology (01-06-2018)
    “…•Renin angiotensin system (RAS) is believed to play a major role in regulating electrolyte balance and blood pressure.•Recent studies have implicated RAS…”
    Get full text
    Journal Article
  15. 15

    Drug-resistant tuberculosis: challenges and opportunities for diagnosis and treatment by Koch, Anastasia, Cox, Helen, Mizrahi, Valerie

    Published in Current opinion in pharmacology (01-10-2018)
    “…[Display omitted] •Management of tuberculosis is complicated by high levels of drug resistance in some regions of the world.•Increasingly, molecular…”
    Get full text
    Journal Article
  16. 16

    PI3K inhibitors in inflammation, autoimmunity and cancer by Stark, Anne-Katrien, Sriskantharajah, Srividya, Hessel, Edith M, Okkenhaug, Klaus

    Published in Current opinion in pharmacology (01-08-2015)
    “…Highlights • Preclinical studies support us of PI3K inhibitors in autoimmunity and inflammation. • First in class PI3K inhibitor has been approved for…”
    Get full text
    Journal Article
  17. 17

    YAP/TAZ as therapeutic targets in cancer by Zanconato, Francesca, Battilana, Giusy, Cordenonsi, Michelangelo, Piccolo, Stefano

    Published in Current opinion in pharmacology (01-08-2016)
    “…Highlights • YAP/TAZ are activated in a broad number of solid tumors. • YAP/TAZ instrumental for tumor initiation, growth, metastasis and chemoresistance. •…”
    Get full text
    Journal Article
  18. 18

    Stem cell-based therapeutic strategies for cartilage defects and osteoarthritis by De Bari, Cosimo, Roelofs, Anke J

    Published in Current opinion in pharmacology (01-06-2018)
    “…•ACI is the gold standard cell therapy for cartilage defect repair.•MSCs are promising substitutes for chondrocytes in ACI-like procedures.•Intra-articular MSC…”
    Get full text
    Journal Article
  19. 19

    Dyslipidemia and diabetes mellitus: Role of lipoprotein species and interrelated pathways of lipid metabolism in diabetes mellitus by Kane, John P., Pullinger, Clive R., Goldfine, Ira D., Malloy, Mary J.

    Published in Current opinion in pharmacology (01-12-2021)
    “…Diabetes mellitus is a complex disease. We are increasingly gaining a better understanding of its mechanisms at the molecular level. From these new insights,…”
    Get full text
    Journal Article
  20. 20

    Cachexia and sarcopenia: mechanisms and potential targets for intervention by Argilés, Josep M, Busquets, Silvia, Stemmler, Britta, López-Soriano, Francisco J

    Published in Current opinion in pharmacology (01-06-2015)
    “…Highlights • Cachexia and sarcopenia share common trends: altered protein synthesis and degradation. • Cachexia and sarcopenia are both driven by inflammation…”
    Get full text
    Journal Article